Correct. B-Vaxx was discontinued due to patent expiry. HER-Vaxx is still in the phase 2 space. There’s very little to be done until the conclusion of the phase 2 combo in 6-12 months time. Good to hear they’re trying to find a deal now and may well have a few interested parties awaiting the phase 2 combo readout. Like Zior, I have no issues with it being de-prioritised… it still has a long patent life and given the company’s current position and pipeline potential, I’d prefer to see a deal done rather than going alone to progress it through registrational trials. Whilst it would be nice to have had a deal announced already, that doesn’t mean to say one won’t be done in the next year or two.
Hopefully people can give some thought to how the prioritisation process might work… do you prioritise the drugs that will take longer to get registered or do you focus on the ones that can be progressed quickly, even if that progression means going into a niche with a smaller market while knowing the first registration in any indication will be the hardest but may quicken the pathway into other indications?
- Forums
- ASX - By Stock
- IMU
- IMU product line - HER-Vaxx
IMU product line - HER-Vaxx, page-45
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.9¢ | $900.1K | 18.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
102 | 15456501 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 1713619 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
102 | 15456501 | 0.048 |
63 | 7620458 | 0.047 |
37 | 4709023 | 0.046 |
53 | 5098365 | 0.045 |
10 | 892291 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 1713619 | 8 |
0.051 | 1155393 | 5 |
0.052 | 1099239 | 8 |
0.053 | 1164182 | 8 |
0.054 | 1092392 | 7 |
Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online